Fig. 8From: Impact of metformin on disease control and survival in patients with head and neck cancer: a retrospective cohort studyImpact of metformin use in T2DM patients with larynx/hypopharynx cancer on a) overall survival, b) disease specific survival and c) recurrence-free survival. Kaplan-Meier analysis with associated p values is demonstradBack to article page